Dowie, J; (2002) Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health economics, 11 (1). pp. 1-8. ISSN 1057-9230 DOI: https://doi.org/10.1002/hec.667 Full text not available from this repository.

Fox-Rushby, JA; Hanson, K; (2001) Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health policy and planning, 16 (3). pp. 326-31. ISSN 0268-1080 https://researchonline.lshtm.ac.uk/id/eprint/16801 Full text not available from this repository.

Gilmore, A; Milne, R; (2001) Methylphenidate in children with hyperactivity: review and cost-utility analysis. Pharmacoepidemiology and drug safety, 10 (2). pp. 85-94. ISSN 1053-8569 DOI: https://doi.org/10.1002/pds.564 Full text not available from this repository.

Smith, RD; Richardson, J; (2005) Can we estimate the 'social' value of a QALY? Four core issues to resolve. Health policy (Amsterdam, Netherlands), 74 (1). pp. 77-84. ISSN 0168-8510 DOI: https://doi.org/10.1016/j.healthpol.2004.12.009 Full text not available from this repository.

Woodhall, SC; Jit, M; Cai, C; Ramsey, T; Zia, S; Crouch, S; Birks, Y; Newton, R; Edmunds, WJ; Lacey, CJ; (2009) Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. Sexually transmitted diseases, 36 (8). pp. 515-21. ISSN 0148-5717 DOI: https://doi.org/10.1097/OLQ.0b013e3181a74c2c Full text not available from this repository.

Burns, T; Knapp, M; Catty, J; Healey, A; Henderson, J; Watt, H; Wright, C; (2001) Home treatment for mental health problems: a systematic review. Health technology assessment (Winchester, England), 5 (15). pp. 1-139. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/15441